PUBLICATIONS · 38662991
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Blood
- Publication date
- 2024 Aug 22
- First author
- Handunnetti SM
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2024 Aug 22;144(8):800-802. doi: 10.1182/blood.2024025021.
- note
- Source null
- related pmid
- 39172439
- relationship
- Comment in
Authors and identifiers
- name
- Handunnetti SM
- type
- Author
- name
- Anderson MA
- type
- Author
- name
- Burbury K
- type
- Author
- name
- Thompson PA
- type
- Author
- name
- Burke G
- type
- Author
- name
- Bressel M
- type
- Author
- name
- Di Iulio J
- type
- Author
- name
- Hicks RJ
- type
- Author
- name
- Westerman D
- type
- Author
- name
- Lade S
- type
- Author
- name
- Pott C
- type
- Author
- name
- Agarwal R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Handunnetti SM
- type
- Author
- name
- Anderson MA
- type
- Author
- name
- Burbury K
- type
- Author
- name
- Thompson PA
- type
- Author
- name
- Burke G
- type
- Author
- name
- Bressel M
- type
- Author
- name
- Di Iulio J
- type
- Author
- name
- Hicks RJ
- type
- Author
- name
- Westerman D
- type
- Author
- name
- Lade S
- type
- Author
- name
- Pott C
- type
- Author
- name
- Agarwal R
- type
- Author
- bibliography ids
- nci-bib-a372f442b1cc9b778f757428
- book metadata
- content sha256
- 3742d918b0df91c8e4c24fa382f47057bd99aeeb8863421ca1cc28739abb75be
- document type
- citation
- dois
- 10.1182/blood.2023023388
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:38662991
- immutable id
- pubmed:38662991@3742d918b0df91c8e4c24fa382f47057bd99aeeb8863421ca1cc28739abb75be
- journal
- abbreviation
- Blood
- issn electronic
- 1528-0020
- issn print
- 0006-4971
- issue
- 8
- name
- Blood
- nlm unique id
- 7603509
- pages
- 867-872
- volume
- 144
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Blood. 2024 Aug 22;144(8):800-802. doi: 10.1182/blood.2024025021.
- note
- Source null
- related pmid
- 39172439
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 38662991
- provenance
- batch id
- 6d213eecf21b6b7867cb
- provider
- NCBI PubMed ESummary
- record sha256
- b01bd1658de328ad9587e7e6d5ba1c1d6bfec0e49bfe29ccb98983ca6cc4bb37
- response sha256
- 684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
- retrieved at
- 2026-09-09T23:48:19.049083+00:00
- publication date
- display
- 2024 Aug 22
- precision
- day
- year
- 2024
- publication types
- Journal Article
- Clinical Trial, Phase II
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.
Preserved source evidence · Not medical advice
Triangle